ClinVar Miner

Submissions for variant NM_006946.4(SPTBN2):c.157+5G>A

gnomAD frequency: 0.00081  dbSNP: rs150159444
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000713027 SCV000227397 uncertain significance not provided 2015-03-04 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000612761 SCV000373435 likely benign Spinocerebellar ataxia type 5 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000612761 SCV000744913 likely benign Spinocerebellar ataxia type 5 2016-06-27 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000713027 SCV000843594 benign not provided 2018-02-26 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000713027 SCV001059597 likely benign not provided 2023-11-24 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001103772 SCV001260579 uncertain significance Autosomal recessive spinocerebellar ataxia 14 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Institute of Human Genetics, University of Leipzig Medical Center RCV000612761 SCV001440076 uncertain significance Spinocerebellar ataxia type 5 2019-01-01 criteria provided, single submitter clinical testing
GeneDx RCV000713027 SCV002072670 uncertain significance not provided 2024-09-28 criteria provided, single submitter clinical testing In silico analysis indicates that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge
CeGaT Center for Human Genetics Tuebingen RCV000713027 SCV005041591 likely benign not provided 2024-06-01 criteria provided, single submitter clinical testing SPTBN2: BP4
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000612761 SCV000733093 likely benign Spinocerebellar ataxia type 5 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV004752774 SCV005346053 likely benign SPTBN2-related disorder 2024-06-02 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.